MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition

Tumor Biology

Volumn 36, Issue 10, 2015, Pages 8121-8126

  Zhang, Liqun ^a   Quan, Hongyu ^b   Wang, Sihai ^a   Li, XueHui ^a   Che, Xiaoyu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

FoxO1; miR 183; Non small cell lung cancer (NSCLC)

Indexed keywords

MICRORNA; MICRORNA 183; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; MESSENGER RNA; MIRN183 MICRORNA, HUMAN; TUMOR MARKER;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER CELL LINE; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; TUMOR GROWTH; ANIMAL; APOPTOSIS; CELL PROLIFERATION; DRUG SCREENING; FEMALE; GENETICS; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84944281344     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3550-8     Document Type: Article

References (20)

1. Caramori G, Casolari P, Cavallesco GN, Giuffre S, Adcock I, Papi A. Mechanisms involved in lung cancer development in copd. Int J Biochem Cell Biol. 2011;43:1030–44.
2. Buttery RC, Rintoul RC, Sethi T. Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol. 2004;36:1154–60.
3. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits mmp9 to prevent metastasis of non-small cell lung cancer. Tumour Biol. 2014;35:11051–6.
4. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits growth of non-small cell lung cancer in vitro and in vivo. Cell Signal. 2015;27:1208–13.
5. Pei J, Lou Y, Zhong R, Han B. Mmp9 activation triggered by epidermal growth factor induced foxo1 nuclear exclusion in non-small cell lung cancer. Tumour Biol. 2014;35:6673–8.
6. Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P. Targeting mir-21 for the therapy of pancreatic cancer. Mol Ther. 2013;21:986–94.
7. Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, et al. Changes in mir-143 and mir-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas. 2012;41:1280–4.
8. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of mir-200 and mir-21 expression by curcumin or its analogue cdf. Cancer Res. 2010;70:3606–17.
9. Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, et al. Mir-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of ezrin in f5m2 cells. Int J Mol Med. 2012;30:1013–20.
10. Shi XY, Gu L, Chen J, Guo XR, Shi YL. Downregulation of mir-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. Int J Mol Med. 2014;33:59–67.
11. Sarver AL, Li L, Subramanian S. Microrna mir-183 functions as an oncogene by targeting the transcription factor egr1 and promoting tumor cell migration. Cancer Res. 2010;70:9570–80.
12. Lowery AJ, Miller N, Dwyer RM, Kerin MJ. Dysregulated mir-183 inhibits migration in breast cancer cells. BMC Cancer. 2010;10:502.
13. Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, et al. Mirna-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting pdcd4. Mol Cells. 2014;37:873–80.
14. Wang G, Mao W, Zheng S. Microrna-183 regulates ezrin expression in lung cancer cells. FEBS Lett. 2008;582:3663–8.
15. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of foxo in the regulation of metabolism. Oncogene. 2008;27:2320–36.
16. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417–23.
17. Tian Z, Yao G, Song H, Zhou Y, Geng J. Igf2r expression is associated with the chemotherapy response and prognosis of patients with advanced nsclc. Cell Physiol Biochem. 2014;34:1578–88.
18. Shi C, Qian J, Ma M, Zhang Y, Han B. Notch 3 protein, not its gene polymorphism, is associated with the chemotherapy response and prognosis of advanced nsclc patients. Cell Physiol Biochem. 2014;34:743–52.
19. Song W, Li Q, Wang L, Wang L. Modulation of foxo1 expression by mir-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol Biochem. 2015;35:184–90.
20. Chang YW, Zhao YF, Cao YL, Gu XF, Li ZQ, Wang SQ, et al. Liver x receptor alpha inhibits osteosarcoma cell proliferation through up-regulation of foxo1. Cell Physiol Biochem. 2013;32:180–6.